Company / Total Assets
Rani Therapeutics Holdings, Inc. Total Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$58.6M
FY2025
5-year range
$36.6M / $124.2M
FY2021-FY2025
Trend
+60.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $59M.
Based on SEC 10-K filings.
$59M in FY2025 with a 3-year CAGR of -18.4%.
Declined from $108M to $59M over the past 3 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -18.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -18.4%, indicating a declining trend.
- In FY2025, total assets increased 60.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $58.6M | +60.0% |
| FY2024 | $36.6M | -66.1% |
| FY2022 | $108.0M | -13.0% |
| FY2021 | $124.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026